About Metrogel® 1%

Once-daily METROGEL (metronidazole) Gel, 1% is a topical gel that’s proven to effectively treat the bumps and blemishes associated with rosacea. It has a unique patent-protected formula that includes vitamin B3 to help retain your skin's natural moisture. It is also the only branded prescription rosacea treatment that provides a measured dose for consistent delivery. Keep reading below to learn more about METROGEL 1% features.

Proven Effective

For an idea of METROGEL 1% effectiveness, just look at its prescription record: it's the #1 prescribed topical rosacea product for more than 10 years. METROGEL 1% is also proven to work with just one application per day, and it has a unique formula that enhances medication absorption while conditioning your skin.

Made with a unique formula

HSA-3® is what truly makes METROGEL 1% different. But what is it? It’s a formula that combines three ingredients that together improve how the METROGEL 1% solution works on your skin, enhancing absorption of the active ingredient, metronidazole, while also helping to retain your skin's natural moisture.

Available in a measured-dose pump

The METROGEL 1% Pump is the only branded prescription rosacea treatment delivery system of its kind. Learn more about the treatment delivery system - take an interactive tour of the pump now.


IMPORTANT SAFETY INFORMATION

Indication: METROGEL® 1% is indicated for the topical treatment of the inflammatory lesions of rosacea. Adverse Events: In controlled clinical studies, the most commonly reported adverse events (>2%) in patients treated with METROGEL 1% were nasopharyngitis, upper respiratory tract infection, and headache. Other adverse experiences reported when using topical metronidazole include skin irritation, transient redness, metallic taste, tingling or numbness of the extremities and nausea. Warnings/Precautions: METROGEL 1% should not be used by patients who are allergic to metronidazole or any ingredient in METROGEL 1%. Avoid contact of METROGEL 1% with the eyes as it may cause tearing. METROGEL 1% should be used with caution in patients with evidence of, or a history of, blood dyscrasia, and with patients taking blood thinning agents as they may experience prolonged prothrombin times. METROGEL 1% treatment should be discontinued if numbness or paresthesia of any extremity should occur.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.